Innovations in Cancer Research and Oncology

Continuous Anticancer drug discovery and development is difficult to find a complete cure for cancer. Due to the drug resistance developed by tumour cells for existing treatments, this is becoming a mandatory approach to fight the disease.



Scientific investigations on inhibitors of checkpoint CHK1 can be another milestone for anticancer drug discovery approach.Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.Deregulated apoptosis is hallmark of cancer and Bcl-2 family of proteins are pivotal to mediating the pathway of this process. Inhibiting their process can be a significant way for developing new anticancer drugs. Many plant sources are known to be important sources of novel anti-cancer properties.


    Related Conference of Innovations in Cancer Research and Oncology

    October 04-05, 2023

    8th Global Summit on Cancer Science and Oncology

    Barcelona, Spain
    November 08-09, 2023

    International Conference on Cancer Biology and Therapeutics

    Budapest, Hungary
    November 15-16, 2023

    36th Conference on Preventive Oncology and Diagnostic Cancer

    Edinburgh, Scotland
    December 14-15, 2023

    5th International Conference on Oncology and Cancer

    Rome, Italy
    February 22-23, 2024

    14th World Congress on Breast Cancer

    Zurich, Switzerland
    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    March 21-22, 2024

    8th Global Meeting on Oncology and Radiology

    Paris, France
    April 18-19, 2024

    24th World Congress on Cancer and Diagnostics

    Dubai, UAE

    Innovations in Cancer Research and Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in